The PROGRESS project, a national pharmacogenomics research study, is transforming primary care by incorporating genetic insights into everyday prescribing practices across England. Pharmacogenomics ...

A landmark partnership agreement between Manchester University NHS Foundation Trust (MFT) and Manchester Metropolitan University (Manchester Met) will aim to reduce health inequalities in the region ...

Manchester University NHS Foundation Trust (MFT) is working with Manchester Metropolitan University’s (MMU) Diverse Talent Scheme which gives graduates with neurodiverse conditions the opportunity to ...

Patients across GM and the UK, will have greater access to cutting-edge treatments and clinical trials following a government announcement of £100m of private investment to set up local research hubs.

Resistance to commonly prescribed antibiotics is becoming one of the biggest global health challenges today. The NIHR Centre for Precision Approaches to Combatting Antimicrobial Resistance at ...

We care for over one million patients each year, and manage over 800 clinical research studies at any one time. Through our Research and Innovation Division, supported by the National Institute for ...

Adam oversees and leads on communications for the Research and Innovation Division at MFT, as well as our wider GM research partnerships; NIHR Manchester BRC and NIHR Manchester CRF.

Our patients are regularly the first-in-the-world to have the opportunity to trial new treatments, and even more are first in the UK. Research and innovation are key to achieving our vision to be ...

Suzanne is a Consultant Paediatrician and researcher at Royal Manchester Children's Hospital with a special interest in epilepsy.

Deputy Director NIHR Manchester Clinical Research Facility at Wythenshawe Hospital Dr Alexander Horsley is a leading expert in cystic fibrosis and Deputy Director of ...